Logo-jrip
J Renal Inj Prev. 2022;11(2): e31957. doi: 10.34172/jrip.2022.31957

Original

On admission hemoglobin and albumin, as the two novel factors associated with thrombosis in COVID-19 pneumonia

Somayeh Sadeghi 1,2 ORCID, Peiman Nasri 3,4 ORCID, Maryam Nasirian 2,5 ORCID, Maryam Sadat Mirenayat 6 ORCID, Arash Toghyani 7 ORCID, Mohammadsaeid Khaksar 8 ORCID, Elahe Nasri 2 ORCID, Ali Safaei 9 ORCID, Hamed Fakhim 2 ORCID, Elham Raofi 8 ORCID, Koorosh Nemati 10 ORCID, Hurie Hashemi 8 ORCID, Elaheh Keivany 8 * ORCID

Cited by CrossRef: 2


1- Sadeghi S, Naderi Z, Arezoomandi N, Saghaei M, Tavakoli F, Hajizadeh M. Use of Immune Modulating Agents to Regulate Hyperinflammation in Severe COVID 19: Assessment of Tocilizumab Use in Combination with Steroids. 2024;13(4):111 [Crossref]
2- Sadeghi A, Sadeghi S, Peikar M, Yazdi M, Sharifi M, Ghafel S, Khorvash F, Ataei B, Safavi M, Nasri E. Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection. Blood Res. 2023;58(2):91 [Crossref]